Alnylam Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
1,665
Employees1,665
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
1,665
Employees1,665

ALNY Key Statistics

Market cap
29.31B
Market cap29.31B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
760.21K
Average volume760.21K
High today
High today
Low today
Low today
Open price
$207.21
Open price$207.21
Volume
0.00
Volume0.00
52 Week high
$236.80
52 Week high$236.80
52 Week low
$117.58
52 Week low$117.58

Analyst ratings

64%

of 25 ratings
Buy
64%
Hold
36%
Sell
0%

ALNY Earnings

-$2.03
-$1.35
-$0.68
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 9, Pre-Market
ActualExpected Feb 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.